New puberty blockers trial to begin after UK ban - BBC

New puberty blockers trial to begin after UK ban  BBC

Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled...

Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials  Nature

The FDA Has Cleared the First Clinical Trial Application for a Prime Editor - CRISPR Medicine News

The FDA Has Cleared the First Clinical Trial Application for a Prime Editor  CRISPR Medicine News

Biological, clinical, and ethical advances of placebo effects - The Lancet

Biological, clinical, and ethical advances of placebo effects  The Lancet

Coronavirus and Ebola Together Test a Beleaguered Congo - WSJ

Coronavirus and Ebola Together Test a Beleaguered Congo  WSJ

Avistone Announces Preclinical Results for ANS03, a Novel Type II ROS1/NTRK Inhibitor in Overcomi...

Avistone Announces Preclinical Results for ANS03, a Novel Type II ROS1/NTRK Inhibitor in Overcoming Clinically Relevant ROS1/NTRK Resistance Mutations at AACR Annual Meeting 2025  BioSpace

Compass plans IPO to take 'magic mushroom' drug to phase 3 - Fierce Biotech

Compass plans IPO to take 'magic mushroom' drug to phase 3  Fierce Biotech

Clara Health launches initiative to match patients to COVID-19 clinical trials - Fierce Healthcare

Clara Health launches initiative to match patients to COVID-19 clinical trials  Fierce Healthcare

Antibody wipeout found to relieve chronic fatigue syndrome - New Scientist

Antibody wipeout found to relieve chronic fatigue syndrome  New Scientist